Optic Neuritis Drug Market By Type ( Oral corticosteroid, Intravenous corticosteroid ), By End-user ( Adult, Pediatric ), By Distribution Channel ( Hospitals, Ophthalmic clinics, Ambulatory surgical centers ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 168

 ERC 6453


Optic Neuritis Drug Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Optic neuritis is the inflammation of optic nerves that can result into optic neuropathy. It is a serious condition which if not treated well can result into multiple sclerosis. An estimate of 15-20% of the people suffering from optic neuritis are likely to end up suffering with multiple sclerosis. However, only 3% of the population suffering from optic neuritis are expected to lose complete vision and go blind. As per the Optic Neuritis Foundation Inc., adults between the ages of 18-45 years are most prone to such a condition. Females are said to be more prone to optic nerve inflammation as compared to the male gender. As per the research studies, approximately 115 out of 100,00 people have optic neuritis condition in the whole world. The treatment for optic neuritis, which is also called as optic papillitis, is carried out by the consumption of prescribed corticosteroid drugs. The corticosteroid drugs are administered via both intravenous and oral route of administration. The global optic neuritis drug market is expected to witness hurdles in its growth during the upcoming years, owing to the lack of awareness among the common populace regarding optic neuritis and its treatment. In addition, the side-effects of oral consumption of corticosteroids for longer duration can lead to osteoporosis, hypertension, diabetes, and cataract among few others. This in turn diminishes the growth of the global market. However, increasing number of initiatives are being taken for spreading awareness regarding optic neuritis, along with increasing investments for the research and development of optic neuritis drugs. Such measures are anticipated to fuel the growth of the global optic neuritis drug market and offer lucrative opportunities to the market players.

The report provides detailed qualitative and quantitative analysis of the global optic neuritis drug market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type, and end-use in each of the major regions of the world.

Optic Neuritis Drug Market Player Analysis -

The report presents detailed analysis of major players operating in global optic neuritis drug market. Few of them include CHANGZHOU YABANG, GlaxoSmithKline, Supharma Chem, HUBEI KEYI, Sequent Scientifi, Lasa Laboratory Pvt Ltd, K.A.Malle Pharmaceuticals, Leo Bio-Care Pvt., Salius Pharma, Fredun Pharmaceuticals Ltd, Hubei Zhongjia-chem Pharmaceutical, Ashish Life Science Pvt. Ltd., AdvacarePharma, MANAV DRUGS, and Huazhong Pharmaceutical. Detailed coverage on these market players with information on their revenue from optic neuritis drug business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global optic neuritis drug market is segmented on the basis of type, end-use, and geography. On the basis of type, the market is categorized into tablets and capsules. By end-use, the market is segmented into ascaris infection treatment, pinworm infection treatment, and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Optic Neuritis Drug Market Segmentation

By Type
   • Oral corticosteroid
   • Intravenous corticosteroid
   • Others

By End-user
   • Adult
   • Pediatric

By Distribution Channel
   • Hospitals
   • Ophthalmic clinics
   • Ambulatory surgical centers

By Geography
   • North America
            o U.S.
            o Canada
            o Mexico
   • Europe
            o U.K
            o France
            o Germany
            o Italy
            o Spain
            o Rest of Europe
   • Asia-Pacific
            o China
            o Japan
            o India
            o Korea
            o Rest of APAC
   • South America
            o Brazil
            o Rest of South America
   • Rest of the World
            o Middle East
            o Africa

Optic Neuritis Drug Market Key Players

• Amgen Inc
• BioAxone BioSciences Inc
• Allergan Pharmaceuticals Ireland
• Ironwood Pharmaceuticals Inc
• Sicor Societa’ Italiana Corticosteroidi S.R.L
• Quark Pharmaceuticals Inc
• Regenera Pharma Ltd
• Shandong Xinhua Pharmaceutical
• Shanghai General Pharmaceutical
• HPGC & CR Zizhu
• Regeneron Pharmaceuticals Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Optic Neuritis Drug Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Optic Neuritis Drug Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!